Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail

Table 4

Efficacy of FZHY on TCM syndrome score in HBC.

TCM Syndrome	Treatment	FZHY group	Placebo group	P value
		(mean ± SD)	(mean ± SD)
LSS (𝑛=23)	Before	28.00±9.01	30.91±11.90	0.5135
	After	17.33±7.98	25.00±8.77	0.0396
	P value	0.0056	0.2000
SDDOS (𝑛=29)	Before	21.05±10.68	19.60±9.83	0.7237
	After	13.63±6.37	14.00±10.54	0.9071
	P value	0.0134	0.2351
DHAS (𝑛=29)	Before	27.13±9.79	27.21±15.03	0.9863
	After	15.80±13.29	16.00±14.02	0.9688
	P value	0.0128	0.0515
LKYDS (𝑛=28)	Before	24.30±6.63	21.06±8.31	0.2997
	After	9.40±5.74	15.61±7.93	0.0392
	P value	<0.0001	0.0524
BSS (𝑛=32)	Before	29.53±15.50	37.41±13.44	0.1338
	After	20.07±13.69	24.88±13.44	0.3240
	P value	0.0871	0.0105
SKYDS (𝑛=6)	Before	25.50±5.97	28.50±6.36	0.5989
	After	16.00±6.68	15.00±9.90	0.8868
	P value	0.0783	0.2462